Extracellular products (ECPs) of the pathogenic Vibrio aestuarianus 01/32 were previously reported to display lethality in Crassostrea gigas oysters and to cause morphological changes and immunosuppression in oyster hemocytes. To identify the source of this toxicity, biochemical and genetic approaches were developed. ECP protease activity and lethality were shown to be significantly reduced following incubation with metal chelators, suggesting the involvement of a zinc metalloprotease. An open reading frame of 1836 bp encoding a 611-aa metalloprotease (designated Vam) was identified. The deduced protein sequence showed high homology to other Vibrio metalloproteases reported to be involved in pathogenicity. To further confirm the role of this enzyme in ECP toxicity, a plasmid carrying the vam gene under the control of an araC-P BAD expression cassette was transferred to a Vibrio splendidus related strain, LMG20012
Introduction
Vibrio aestuarianus is a naturally occurring gram-negative bacterium, widely spread in marine ecosystems [1] . Recent epidemiological studies conducted during recurrent summer mortality events of Crassostrea gigas oysters along the French Atlantic coast have also documented the predominance of this bacterial species in the hemolymph of diseased animals, and have demonstrated its pathogenicity to C. gigas by experimental challenge [2] [3] [4] . Previous studies designed to understand V. aestuarianus pathogenicity mechanisms have shown that one of the isolated strains, named 01/32, secretes extracellular products (ECPs) which induce immunosuppressant activities on C. gigas hemocyte functions in vitro and display lethality to oysters in vivo [5] . During the time course of infection, this bacterial isolate was also reported to circumvent the host cellular immune defenses [6] . However, the mechanisms and bacterial effector(s) responsible for these immunomodulatory and toxic effects remain poorly understood.
Since we previously established that V. aestuarianus 01/32 releases bacterial proteases into the host hemolymph during infection, we hypothesized that these proteases may be responsible, either directly or indirectly, for some of the observed pathological signs. Indeed, the pathogenesis of Vibrionaceae associated with marine invertebrate infections has frequently been linked with the production of extracellular proteases [7] [8] [9] . To date, only two studies have genetically demonstrated the causal relationship between proteases and virulence in these Vibrio agents, thus fulfilling the molecular version of Koch's postulates [10, 11] . The most common procedure to prove cause-effect relationships for suspected bacterial virulence factors relies on loss-of-function studies using reverse genetic methods. However, genetic tools are sometimes not available in bacterial species of environmental origin because of either inoperative or inefficient DNA transformation, poor DNA delivery or inefficient allelic exchange. For such cases, gene expression in a heterologous system constitutes a useful alternative. A potential difficulty with this approach is that genes from heterologous systems may have adverse effects on cell growth and viability when expressed in E. coli [12] . We recently characterized a close phylogenetic neighbor of V. aestuarianus, belonging to the V. splendidus polyphyletic group [13] . This strain, named LMG20012 T and previously reported to be non pathogenic to oysters, can be easily manipulated genetically and is devoid of any protease activity [14] . Considering all these features, the V. splendidus related strain LMG20012
T constitutes an excellent candidate for heterologous expression of V. aestuarianus proteases. In the present study, a biochemical approach allowed us to associate V. aestuarianus ECP protease activity and lethality to oysters with the involvement of a metalloprotease-like enzyme. After identification of this factor, we successfully used LMG20012
T to heterologously express the V. aestuarianus zinc metalloprotease and genetically demonstrate its role in toxicity to C. gigas and impairment of oyster immune cells.
Material and methods

Bacterial strains and media.
Bacterial strains and plasmids used in this study are listed in Table 1 . V. aestuarianus and V. splendidus related strain LMG20012
T were routinely grown in Luria-Bertani (LB) broth 0.5 M NaCl or marine broth (MB), or on marine agar (MA) at 20°C. Escherichia coli strains were grown in LB at 37°C. Ampicillin (Ap) and chloramphenicol (Cm) (Difco Antibiotics) were used at a final concentration of 100 µg.mL -1 and 12,5 µg.mL -1 , respectively. Diaminopimelate (DAP) was supplemented when necessary to a final concentration of 0.3 mM. Gene expression under the control of the P BAD promoter was activated or repressed by addition to the growth medium of 1% Larabinose or 1% D-glucose, respectively.
Preparation of extracellular products and protease activity assays.
Extracellular products (ECPs) were produced by the cellophane overlay method and their protease activity determined using azocasein, as previously described [6] . Briefly, crude ECPs (5 μl) were added to 250 μl of azocasein (5 mg.mL -1 in 50 mM Tris-HCl buffer pH 8.0) and to 245 µl of distilled water. The mixture was incubated at 20°C for 10 min. The undigested substrate was precipitated by adding 500 μl of 10 % trichloroacetic acid to the reaction mixture, followed by centrifugation at 12 000 g and 4°C for 5 min. The supernatant (500 μl) was neutralized by the addition of an equal volume of 1 M NaOH. After mixing, the absorbance was measured at 440 nm for triplicate samples. One unit of protease activity was defined as the amount of enzyme that caused an increase of one absorbance unit under the conditions of the assay. ECP protease activity of V. aestuarianus 01/32 was evaluated in the presence of commercially available protease inhibitors (Sigma) and compared to that of the control ( Table 2 ).
Polymerase chain reaction (PCR).
Genomic DNA from V. aestuarianus 01/32 was purified using the standard phenol-chloroform extraction method [15] . PCR was done in 50-L volumes using the Pfu DNA polymerase (Promega) following the manufacturer's instructions. Other PCRs were performed in 50-L volumes using Bioline Taq polymerase according to the manufacturer's instructions. Primers used in PCR reactions are listed in Table 3 . Conditions for amplification were as follows: 
Plasmid construction.
Plasmid pSU18-oriT-araC-P BAD vam was constructed by introducing the vam gene in pSU18-oriTaraC-P BAD gfp plasmid through a two-step PCR method [16] . The vam gene was amplified using primers Vam1C and Vam2 from genomic DNA of V. aestuarianus strain 01/32, while the plasmid pSU18-oriT-araC-P BAD gfp was amplified using primers Vam1 and Vam3. After gel purification, a PCR assembly was set up by mixing together 100 ng of the two fragments and the most external primers, Vam2 and Vam3. The final product was digested with XhoI and self-ligated before DH5 transformation. After sequence confirmation, the pSU18-oriT-araC-P BAD vam plasmid was transferred to 2163 cells and conjugation with LMG20012
T was performed by the filter mating procedure as previously described [14] .
Protein identification by peptide mass fingerprinting.
To evaluate Vam metalloprotease production of the resulting transconjuguant, ECPs were subjected to MS and MS/MS analyses, as previously described [17] .
In vivo assays.
In vivo assays were performed on one-year-old oysters C. gigas following previously described procedures [5, 6] . Briefly, toxicity inhibition was assayed by incubating ECPs with 50 mM EGTA for 1 h and then injecting oysters (3 replicate tanks, 10 oysters per tank) with 200 µL of the resulting mixture (5 µg T transconjuguants, as previously described [5] . Observations were made twice a day, and mortalities were recorded for 2-days after inoculation.
In vitro assays : hemocyte cellular parameters.
ECPs of V. splendidus related strain LMG20012
T carrying the pSU18-oriT-araC-P BAD vam plasmid and grown under repressing (by addition of 1% D-glucose) or inducing (by addition of 1% Larabinose) conditions were tested at 2, 8 and 32 µg.mL -1 for hemocyte phagocytosis and adhesion assays. ECPs from V. aestuarianus 01/32 in the same concentration range were also included in the experimental design. Briefly, 4 pools comprised of 4-5 individual hemolymph samples were prepared for each treatment. Hemocyte phagocytic activity was assayed by distributing 150 µL sub-samples of each hemolymph pool into 5 mL polystyrene tubes (Falcon) maintained on ice. Each sub-sample received a 150 µL volume of the ECPs to be tested. A negative control was included by adding a 150 µL volume of filtered sterile seawater (FSSW) to one sub-sample of each pool. Each sub-sample was subsequently incubated at 18°C for 60 min with fluorescent beads (Fluoresbrite, YG Microspheres, 2 µm, Polysciences) at a final concentration of 0.2 % of the commercial solution. Results of phagocytosis were expressed as the percentage of hemocytes containing three beads or more [5] . Hemocyte adhesive capacities were assessed by adding a 100 µL volume of the ECPs to be tested or 100 µL of FSSW as a control to 100 µL sub-samples of each hemolymph pool. After three hours of incubation at 18°C, the percentage of adhering hemocytes was calculated relatively to the initial total hemocyte count of the tested pool [5] .
Statistical analyses
Significant differences between treatments were tested by one-way analysis of variance (ANOVA) using Statgraphics Plus 5.0 software. Data collected as percentages were transformed (arcsine of the square root) before analysis. The method used to discriminate among the means was Fisher's least significant difference (LSD) procedure. Results were deemed significant at P<0.05
Results
V. aestuarianus 01/32 ECPs display a metalloenzyme-like activity associated with toxicity.
Experiments were first performed to characterize the protease activity of V. aestuarianus 01/32 ECPs in the presence of protease inhibitors. ECP protease activity was sensitive to EDTA, EGTA and the zinc specific metal chelator 1,10-phenanthroline (Table 2 ). In contrast, these ECPs were resistant to the serine protease inhibitor PMSF. Inactivation of the ECPs by 1,10-phenanthroline could be reversed to near-control levels by titration with 0.5 and 1 mM Zn
2+
. Taken together, these results suggest that the protease activity of ECPs was due to one or more zinc-dependent metalloenzyme(s). To investigate the role of this protease(s) in oyster lethality, toxicity inhibition tests were performed by inactivating the ECP metalloprotease activity with 50 mM EGTA. Incubation of ECPs with EGTA prior to injection significantly reduced their toxicity (33  2.5 % cumulative mortality) compared to animals injected with crude ECPs (98  3.5 % cumulative mortality). Cumulative mortality of control oysters did not exceed 3% throughout the experiment.
The vam gene encodes a zinc-dependent metalloprotease.
The structural gene coding for the metalloprotease (designated Vam for Vibrio aestuarianus metalloprotease) was characterized. The vam gene consists of a 1836-bp open reading frame encoding a putative 611-amino-acid protein, with a calculated molecular mass of 66,3 kDa. A cleavage site is predicted to take place at the C-terminus of the Ala 25 [18, 19] . A putative prosequence of 174 aa (Ala 26 to His
199
) was identified between the end of the putative signal peptide sequence and the beginning of the mature protein, in agreement with the long propeptides (172 and 174 aa) proposed for the metalloprotease precursors of V. proteolyticus [20] and V. anguillarum [21] , were also identified within the deduced amino acid sequence [22] . Homology searches using the Blast algorithm revealed that the Vam sequence exhibited a high degree of homology to other Vibrio metalloproteases, including V. anguillarum EmpA (85% identity).
Vam expression in a heterologous host potentiates the lethal effect of its ECPs.
To investigate the involvement of the vam metalloprotease gene in the toxicity to oysters, vam was expressed under the control of a P BAD promoter in the avirulent LMG20012 T strain. The same plasmid, carrying the gfp gene instead of the vam gene was used as a negative control. The protease activity of ECPs from each conjuguant cultivated in the presence of 1% D-glucose (P BAD promoter repression) or 1% L-arabinose (P BAD promoter induction) was evaluated. Protease activity was only detected in the ECPs of V. splendidus related strain LMG20012 T carrying the vam plasmid upon addition of L-arabinose (140.4  10.6 U.mg -1 ), although this activity was 44% lower than that of ECPs from V. aestuarianus 01/32 (258.4  1.4 U.mg -1 , Table 4 ). Growth in 1% D-glucose very efficiently repressed Vam expression, as no enzymatic activity was quantified. Protease activity was not detected in the ECPs produced by V. splendidus related strain LMG20012 T carrying the gfp plasmid following growth in D-glucose or L-arabinose, confirming previously obtained results [14] . A comparison of tryptic peptide masses from ECPs produced by LMG20012
T carrying the vam plasmid grown under inducing conditions with the deduced aa sequence of the vam gene allowed the identification of four peptides. Molecular masses of all four peptides showed mass matches to the predicted Vam protein sequence, confirming that Vam was readily produced and secreted in the ECPs of the transconjuguant (data not shown). Finally, in vivo LD 50 values were determined for ECPs of each transconjuguant ( 
Recombinant expression of Vam metalloprotease confers cytotoxicity to the
ECPs of the avirulent V. splendidus related strain LMG20012 T .
The ECPs produced by LMG20012
T expressing the vam gene were examined for effects on hemocyte adhesion and phagocytosis. Percentages of adherent hemocytes significantly differed from that of the control following hemocyte exposure to these ECPs at 32 µg.mL -1 (ANOVA, P <0.05) (Fig. 1A) . ECPs from LMG20012
T carrying the vam plasmid and grown under repressing conditions did not affect hemocyte adhesion over the tested range (P >0.05). Compared to the control, V. aestuarianus ECPs displayed a significant inhibition of hemocyte adhesion at all tested concentrations, (P <0.05). Hemocyte phagocytic activity, evaluated using fluorescent beads, was significantly affected by V. aestuarianus ECPs at 8 µg.mL -1 (ANOVA, P <0.05) (Fig. 1B) . Addition of ECPs from LMG20012 T expressing the Vam metalloprotease induced a statistically significant decrease in phagocytic ability at 32 µg.mL -1 (P<0.05). ECPs of LMG20012 T carrying the vam plasmid and grown under repressing conditions did not induce any change, whatever the concentration tested (P < 0.05). After 3 h, oyster hemocytes incubated with filtered sterile seawater (FSSW) appeared healthy, with cytoplasmic extensions (Fig. 2) 
Discussion
Since V. aestuarianus 01/32 was previoulsy demonstrated to release extracellular proteases during infection, we hypothesized that protease secretion might be associated to virulence mechanisms [6] . In this study we showed that ECP toxicity to oysters and metalloprotease activity were correlated. We identified a 1836-bp gene (named vam) encoding a putative protein sharing all the features of the thermolysin family [23] . To demonstrate a cause-effect relationship for the vam gene in pathogenicity, a genetic approach was implemented. For bacterial model organisms, such as V. cholerae, this is usually done by specific inactivation of the candidate gene. We sought to develop a similar strategy here, but conjugation experiments with broad-host range plasmids failed when using V. aestuarianus 01/32 as a recipient, and attempts to transfer plasmids by electroporation were ineffective (data not shown). The vam gene was therefore expressed in a non-pathogenic phylogenetic neighbor, V. splendidus related strain LMG20012 T , using the arabinose inductible promoter P BAD [24] [25] [26] . This allowed us to demonstrate that addition of Larabinose induced protease activity in ECPs prepared from strain LMG20012
T carrying the vam plasmid, although this activity was 1.8-fold less than that of V. aestuarianus. This lowered activity correlated well with toxicity and hemocyte assay results, as i) the LD 50 value of recombinant LMG20012 T ECPs was 2 times higher than that calculated for V. aestuarianus ECPs and ii) these ECPs induced the same immunosuppressant effects on cells as those observed for V. aestuarianus ECPs except only at higher concentrations. The nature of this discrepancy in toxicity remains to be clarified : the araC-P BAD promoter system can be modulated by several factors such as the inducer concentration or the ability of the strain to degrade arabinose [24] . LMG20012
T transconjuguant culture conditions may therefore explain this discrepancy. Another hypothesis relies on an incomplete proteolytic processing of the heterologously expressed enzyme. Metalloproteases are indeed synthesized as inactive precursors inside the cell and undergo several stages of proteolytic processing [27, 28] . Several Vibrio metalloproteases have been shown to be proteolytically activated by additional proteases [29, 30] . Full activity of Vam protease may similarly require cleavage by an accessory protease that could be lacking in the V. splendidus related strain LMG20012 T genetic background. Together, the results presented here clearly indicate the functionality of this expression system, which provides an efficient and inexpensive method for producing an active recombinant protease in the culture medium without the time-consuming need to solubilize the inclusion bodies that may form in E. coli and thus to refold the recombinant protein into its native structure. The data obtained in this study also demonstrate the role of Vam metalloprotease in oyster toxicity and impairment of hemocyte functions. Metalloprotease involvement in bacterial virulence is being extensively studied because of their wide variety of pathological actions [31] . Recently, the role of various Vibrio metalloproteases has been investigated in C. gigas. For instance, the V. tubiashii VtpA metalloprotease is believed to contribute to pathogenicity by degrading oyster larvae tissues, thus providing the pathogen with nutrients [10] . The Vsm metalloenzyme from V. splendidus LGP32 has been shown to display toxicity following ECP injection into oysters and to induce cytotoxicity in snail and mouse fibroblast cell lines [14] . The protozoan parasite Perkinsus marinus, the agent of Dermo disease of the eastern oyster, C. virginica, is known to release during infection several extracellular proteases with serine and metalloproteinase-like activity [32] , that were found to degrade oyster proteins and to decrease hemocyte motility, lysozyme activity and haemagglutinin titres [33, 34] . These proteases are believed to be part of the mechanisms developed by this obligatory intracellular parasite to evade the host immune defense system. The results obtained in this work show that the V. aestuarianus metalloprotease Vam is similarly implicated in avoidance of C. gigas immune responses and reinforce our previous observations indicating that this pathogen may have evolved a so-called "outsider strategy", to promote its own extracellular life cycle within the oyster. The findings of the present work describe a new mode of action for a Vibrio metalloprotease and provide thus new insights to explain how V. aestuarianus 01/32 succeeds in avoiding phagocytic engulfment in order to successfully replicate within the host, ultimately leading to death. To date, the biochemical mechanisms behind Vam impairement of oyster hemocyte functions remain unknown. In light of obtained data, it is likely that Vam affects protein structures required for hemocytes to keep their normal morphology and develop a phagocytic activity. Indeed, a number of bacterial cytotoxins have been shown to act on the eukaryotic cell cytoskeleton as part of their virulence mechanisms by targeting GTPases from the Rho protein subfamily [35] . GTPases play crucial roles in several cellular processes, including morphogenesis, migration, cytokinesis, and phagocytosis [36] . As compared to vertebrate and invertebrate model organisms, much less is known regarding the cellular and molecular mechanisms involved in phagocytosis in bivalve molluscs. Additional investigations are therefore needed to determine how the Vam metalloprotease modulates hemocyte cell physiology. Overall results of duplicate trial are presented.
Tables
c expressed by dividing the cumulative number of dead oysters with the cumulative total number of oysters injected. Table 4 . Toxicity and specific protease activity of ECPs from V. aestuarianus strain 01/32 and V. splendidus related strain LMG20012 T transconjuguants carrying either the pSU18-oriT-araC-P BAD gfp or pSU18-oriT-araC-P BAD vam plasmid, and grown under 1% L-arabinose. 
